IP Library Granted Patent US 9,347,866
Granted Patent B2
US 9,347,866 · App. 14/696,269 · Granted May 24, 2016

Laser diffraction with inhaler enclosed in positive pressure chamber

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,347,866
App. No.
14/696,269
Granted
May 24, 2016
Kind
B2
Abstract

The present disclosure relates to an improved device and methods for adapting to a laser diffraction apparatus used for measuring particle size distribution and density of the plume of a powder composition emitted from a dry powder inhaler.

Claims (25)

1. A method of measuring particle size distribution of a powder formulation, comprising:

providing a device comprising a chamber and configured an adaptor to hold a breath-powered, dry powder inhaler in a closed environment;

installing said breath-powered inhaler in said adaptor chamber, said breath-powered inhaler comprising a cartridge and comprising a dry powder formulation;

providing positive pressure into said chamber of said device to generate a flow of air or gas through said dry powder inhaler;

measuring with the laser diffraction apparatus the particle size distribution of the particles emitted from the inhaler into a chamberless area outside the device in an ambient environment; and

vacuuming said powder particles into a disposable syatem.

2. The method of claim 1 , wherein the breath-powered, dry powder inhaler comprises a mouthpiece.

3. The method of claim 2 , wherein said mouthpiece forms an air pathway from the chamber to the chamberless area.

4. The method of claim 1 , wherein the step of providing positive pressure into said chamber is attained by a source of pressurized gas from a flow controller system comprising a valve or a syringe pump.

5. The method of claim 1 , wherein the positive pressure applied is greater than 1 kPa.

6. The method of claim 1 , wherein the step of measuring the particle size distribution of the powder formulation occurs concurrently with emission of particles from the dry powder inhaler.

7. A method of measuring at least one particle size distribution of a powder formulation comprising;

providing positive pressure into a chamber configured having an adaptor to hold an inhaler in a closed environment to emit particles of a formulation housed within the inhaler into a chamberless area outside the chamber in an ambient environment, and

measuring said particles size distribution with a laser diffraction appratus.

8. The method of claim 7 , wherein the inhaler comprises a mouthpiece.

9. The method of claim 8 , wherein said mouthpiece forms an air pathway from the chamber to the chamberless area.

10. The method of claim 7 , wherein the step of providing positive pressure into said chamber is attained by a source of pressurized gas from a flow controller system comprising a valve or a syringe pump.

11. The method of claim 7 , wherein the positive pressure applied is greater than 1 kPa.

12. The method of claim 7 , wherein the step of measuring the particle size distribution of the powder formulation occurs concurrently with emission of particles from the inhaler.

13. The method of claim 7 , wherein the inhaler is a breath powered, dry powder inhaler.

14. The method of claim 7 , wherein the formulation is a dry powder.

15. A method of measuring particle size distribution of a powder formulation with a laser diffraction apparatus, comprising;

providing positive pressure into a chamber configured with an adaptor to hold a breath-powered, dry powder inhaler including a mouthpiece in a closed environment to create a flow of air or gas through said breath powered, dry powder inhaler into a chamberless area outside the chamber in an ambient environment, and

measuring said particle size distribution with the laser diffraction apparatus when particles are emitted from the inhaler,

wherein said mouthpiece forms an air pathway from the chamber to the chamberless area.

Assignments (5)
PATENT SECURITY AGREEMENT Recorded Aug 12, 2025
From: MANNKIND CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 072444/0525 →
RELEASE OF SECURITY INTEREST Recorded Apr 5, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: MANNKIND CORPORATION; MANNKIND LLC
Reel/Frame 067024/0082 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2019
From: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
To: MANNKIND CORPORATION
Reel/Frame 050044/0138 →
SECURITY INTEREST Recorded Aug 13, 2019
From: MANNKIND CORPORATION; MANNKIND LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050044/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2015
From: ADAMO, BENOIT; SHAH, SAIYAM; SMUTNEY, CHAD C.
To: MANNKIND CORPORATION
Reel/Frame 036083/0087 →